General Meeting, new call
Europlasma's Annual General Meeting of the Shareholders met on June 21, 2018, under the chairmanship of Pierre Catlin, was not able to deliberate for lack of quorum due to a large float.
Read the press release (in French)
Number of shares and voting rights as at 31/05/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st May.
Number of shares and voting rights as at 30/04/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 30th April.
Availability of the 2017 Registration Document
Europlasma announces that its 2017 Registration Document ("Document de Référence 2017") has been filed today with the "Autorité des Marchés Financiers" (AMF) under the number D.18-0436.
Read the press release in French
Europlasma announces an agreement with European High Growth Opportunities Securitization Fund improving the conditions of the 3rd tranche of convertible bonds
In accordance with the bond financing agreement and the schedule published, the third warrant of convertible bonds into shares (BEOCA) has been automatically exercised by the investor, European High Growth Opportunities Securitization Fund.
Read the press release (in French)
Number of shares and voting rights as at 28/02/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 28th February.
Convertible bonds financing contract for a maximum amount of EUR 8 million
Europlasma signed today a contract for the issuance of convertible bonds into shares with the Luxembourg European High Growth Opportunities Securitization Fund.
Number of shares and voting rights as at 31/01/2018
Europlasma declares the number of voting rights and shares comprising its share capital as at 31st January.
Half-year report on liquidity contract as at 31/12/2017
Under the liquidity contract agreed between the company and Kepler Cheuvreux, as at 31 December 2017.